Why START? Reflections that led to the conduct of this large long-term strategic HIV trial
INSIGHT Strategic Timing of AntiRetroviral Treatment (START) Study Group, Jens Lundgren, Abdel Babiker, Fred Gordin, Sean Emery, Gerd Fätkenheuer, Jean-Michel Molina, Robin Wood, James D Neaton
No abstract availableKeywords: CD4-guided ART; HIV; START trial; antiretroviral therapy; when to start.
Figures
Source: PubMed